| Year |
Citation |
Score |
| 2023 |
Park Y, Korzun T, Moses AS, Singh P, Levasseur PR, Demessie AA, Sharma KS, Morgan T, Raitmayr CJ, Avila U, Sabei FY, Taratula OR, Marks DL, Taratula O. Targeted Nanocarriers for Systemic Delivery of IRAK4 Inhibitors to Inflamed Tissues. Small (Weinheim An Der Bergstrasse, Germany). e2306270. PMID 37702136 DOI: 10.1002/smll.202306270 |
0.762 |
|
| 2023 |
Korzun T, Moses AS, Diba P, Sattler AL, Taratula OR, Sahay G, Taratula O, Marks DL. From Bench to Bedside: Implications of Lipid Nanoparticle Carrier Reactogenicity for Advancing Nucleic Acid Therapeutics. Pharmaceuticals (Basel, Switzerland). 16. PMID 37631003 DOI: 10.3390/ph16081088 |
0.771 |
|
| 2023 |
Korzun T, Moses AS, Diba P, Sattler AL, Olson B, Taratula OR, Pejovic T, Marks DL, Taratula O. Development and Perspectives: Multifunctional Nucleic Acid Nanomedicines for Treatment of Gynecological Cancers. Small (Weinheim An Der Bergstrasse, Germany). e2301776. PMID 37518857 DOI: 10.1002/smll.202301776 |
0.771 |
|
| 2023 |
Moses AS, Korzun T, Mamnoon B, Baldwin MK, Myatt L, Taratula O, Taratula OR. Nanomedicines for Improved Management of Ectopic Pregnancy: A Narrative Review. Small (Weinheim An Der Bergstrasse, Germany). e2301873. PMID 37471169 DOI: 10.1002/smll.202301873 |
0.688 |
|
| 2023 |
Taratula O, Taratula OR. Novel Nanoparticle-Based Treatment and Imaging Modalities. Pharmaceutics. 15. PMID 36678873 DOI: 10.3390/pharmaceutics15010244 |
0.33 |
|
| 2023 |
Herrera-Barrera M, Ryals RC, Gautam M, Jozic A, Landry M, Korzun T, Gupta M, Acosta C, Stoddard J, Reynaga R, Tschetter W, Jacomino N, Taratula O, Sun C, Lauer AK, et al. Peptide-guided lipid nanoparticles deliver mRNA to the neural retina of rodents and nonhuman primates. Science Advances. 9: eadd4623. PMID 36630502 DOI: 10.1126/sciadv.add4623 |
0.711 |
|
| 2022 |
St Lorenz A, Moses AS, Mamnoon B, Demessie AA, Park Y, Singh P, Taratula O, Taratula OR. A Photoacoustic Contrast Nanoagent with a Distinct Spectral Signature for Ovarian Cancer Management. Advanced Healthcare Materials. e2202946. PMID 36495088 DOI: 10.1002/adhm.202202946 |
0.33 |
|
| 2022 |
Park Y, Moses AS, Demessie AA, Singh P, Lee H, Korzun T, Taratula OR, Alani AWG, Taratula O. Poly(aspartic acid)-Based Polymeric Nanoparticle for Local and Systemic mRNA Delivery. Molecular Pharmaceutics. PMID 36409995 DOI: 10.1021/acs.molpharmaceut.2c00738 |
0.749 |
|
| 2022 |
Moses AS, Kadam L, St Lorenz A, Baldwin MK, Morgan T, Hebert J, Park Y, Lee H, Demessie AA, Korzun T, Mamnoon B, Alani AWG, Taratula O, Myatt L, Taratula OR. Nano-Theranostic Modality for Visualization of the Placenta and Photo-Hyperthermia for Potential Management of Ectopic Pregnancy. Small (Weinheim An Der Bergstrasse, Germany). e2202343. PMID 36394151 DOI: 10.1002/smll.202202343 |
0.737 |
|
| 2022 |
Demessie AA, Park Y, Singh P, Moses AS, Korzun T, Sabei FY, Albarqi HA, Campos L, Wyatt CR, Farsad K, Dhagat P, Sun C, Taratula OR, Taratula O. An Advanced Thermal Decomposition Method to Produce Magnetic Nanoparticles with Ultrahigh Heating Efficiency for Systemic Magnetic Hyperthermia. Small Methods. e2200916. PMID 36319445 DOI: 10.1002/smtd.202200916 |
0.739 |
|
| 2022 |
Korzun T, Moses AS, Kim J, Patel S, Schumann C, Levasseur PR, Diba P, Olson B, Rebola KGO, Norgard M, Park Y, Demessie AA, Eygeris Y, Grigoriev V, Sundaram S, ... Taratula OR, ... Taratula O, et al. Nanoparticle-Based Follistatin Messenger RNA Therapy for Reprogramming Metastatic Ovarian Cancer and Ameliorating Cancer-Associated Cachexia. Small (Weinheim An Der Bergstrasse, Germany). e2204436. PMID 36098251 DOI: 10.1002/smll.202204436 |
0.778 |
|
| 2022 |
Park Y, Demessie AA, Luo A, Taratula OR, Moses AS, Do P, Campos L, Jahangiri Y, Wyatt CR, Albarqi HA, Farsad K, Slayden OD, Taratula O. Targeted Nanoparticles with High Heating Efficiency for the Treatment of Endometriosis with Systemically Delivered Magnetic Hyperthermia. Small (Weinheim An Der Bergstrasse, Germany). e2107808. PMID 35434932 DOI: 10.1002/smll.202107808 |
0.319 |
|
| 2021 |
Han X, Taratula O, St Lorenz A, Moses AS, Albarqi HA, Jahangiri Y, Wu Q, Xu K, Taratula O, Farsad K. A novel multimodal nanoplatform for targeting tumor necrosis. Rsc Advances. 11: 29486-29497. PMID 35479549 DOI: 10.1039/d1ra05658a |
0.345 |
|
| 2021 |
Moses AS, Demessie AA, Taratula O, Korzun T, Slayden OD, Taratula O. Nanomedicines for Endometriosis: Lessons Learned from Cancer Research. Small (Weinheim An Der Bergstrasse, Germany). e2004975. PMID 33491876 DOI: 10.1002/smll.202004975 |
0.754 |
|
| 2020 |
Albarqi HA, Demessie AA, Sabei FY, Moses AS, Hansen MN, Dhagat P, Taratula OR, Taratula O. Systemically Delivered Magnetic Hyperthermia for Prostate Cancer Treatment. Pharmaceutics. 12. PMID 33113767 DOI: 10.3390/pharmaceutics12111020 |
0.318 |
|
| 2020 |
Moses AS, Taratula OR, Lee H, Luo F, Grenz T, Korzun T, Lorenz AS, Sabei FY, Bracha S, Alani AWG, Slayden OD, Taratula O. Nanoparticle-Based Platform for Activatable Fluorescence Imaging and Photothermal Ablation of Endometriosis. Small (Weinheim An Der Bergstrasse, Germany). e1906936. PMID 32250034 DOI: 10.1002/Smll.201906936 |
0.738 |
|
| 2020 |
Han X, Taratula O, Taratula O, Xu K, St Lorenz A, Moses A, Jahangiri Y, Yu G, Farsad K. Biodegradable hypericin-containing nanoparticles for necrosis targeting and fluorescence imaging. Molecular Pharmaceutics. PMID 32212709 DOI: 10.1021/Acs.Molpharmaceut.9B01238 |
0.341 |
|
| 2020 |
Moses AS, Taratula OR, Lee H, Luo F, Grenz T, Korzun T, Lorenz AS, Sabei FY, Bracha S, Alani AWG, Slayden OD, Taratula O. Endometriosis Treatment: Nanoparticle‐Based Platform for Activatable Fluorescence Imaging and Photothermal Ablation of Endometriosis (Small 18/2020) Small. 16: 2070101. DOI: 10.1002/Smll.202070101 |
0.684 |
|
| 2019 |
Garbuzenko OB, Kuzmov A, Taratula O, Pine SR, Minko T. Strategy to enhance lung cancer treatment by five essential elements: inhalation delivery, nanotechnology, tumor-receptor targeting, chemo- and gene therapy. Theranostics. 9: 8362-8376. PMID 31754402 DOI: 10.7150/Thno.39816 |
0.617 |
|
| 2019 |
Majumder J, Taratula O, Minko T. Nanocarrier-based systems for targeted and site specific therapeutic delivery. Advanced Drug Delivery Reviews. PMID 31400350 DOI: 10.1016/J.Addr.2019.07.010 |
0.593 |
|
| 2019 |
Taratula OR, Taratula O, Han X, Jahangiri Y, Tomozawa Y, Horikawa M, Uchida B, Albarqi HA, Schumann C, Bracha S, Korzun T, Farsad K. Transarterial Delivery of a Biodegradable Single-Agent Theranostic Nanoprobe for Liver Tumor Imaging and Combinatorial Phototherapy. Journal of Vascular and Interventional Radiology : Jvir. PMID 31202675 DOI: 10.1016/J.Jvir.2019.03.004 |
0.731 |
|
| 2019 |
Albarqi HA, Wong LH, Schumann C, Sabei FY, Korzun T, Li X, Hansen MN, Dhagat P, Moses AS, Taratula O, Taratula O. Biocompatible Nanoclusters with High Heating Efficiency for Systemically Delivered Magnetic Hyperthermia. Acs Nano. PMID 31082199 DOI: 10.1021/Acsnano.8B06542 |
0.755 |
|
| 2018 |
Schumann C, Nguyen DX, Norgard M, Bortnyak Y, Korzun T, Chan S, Lorenz AS, Moses AS, Albarqi HA, Wong L, Michaelis K, Zhu X, Alani AWG, Taratula OR, Krasnow S, ... ... Taratula O, et al. Increasing lean muscle mass in mice via nanoparticle-mediated hepatic delivery of follistatin mRNA. Theranostics. 8: 5276-5288. PMID 30555546 DOI: 10.7150/Thno.27847 |
0.751 |
|
| 2018 |
Schumann C, Chan S, Millar JA, Bortnyak Y, Carey K, Fedchyk A, Wong L, Korzun T, Moses AS, Lorenz A, Shea D, Taratula O, Khalimonchuk O, Taratula O. Intraperitoneal Nanotherapy for Metastatic Ovarian Cancer Based on siRNA-Mediated Suppression of DJ-1 Protein Combined with a Low Dose of Cisplatin. Nanomedicine : Nanotechnology, Biology, and Medicine. PMID 29635082 DOI: 10.1016/J.Nano.2018.03.005 |
0.739 |
|
| 2018 |
Li X, Schumann C, Albarqi HA, Lee CJ, Alani AWG, Bracha S, Milovancev M, Taratula O, Taratula O. A Tumor-Activatable Theranostic Nanomedicine Platform for NIR Fluorescence-Guided Surgery and Combinatorial Phototherapy. Theranostics. 8: 767-784. PMID 29344305 DOI: 10.7150/Thno.21209 |
0.362 |
|
| 2017 |
Goloviznina NA, Verghese SC, Yoon YM, Taratula O, Marks DL, Kurre P. Mesenchymal stromal cell-derived extracellular vesicles promote myeloid-biased multipotent hematopoietic progenitor expansion via Toll-like receptor engagement. The Journal of Biological Chemistry. 292: 3541. PMID 28235900 DOI: 10.1074/jbc.A116.745653 |
0.386 |
|
| 2016 |
Duong T, Li X, Yang B, Schumann C, Albarqi HA, Taratula O, Taratula O. Phototheranostic Nanoplatform Based on a Single Cyanine Dye for Image-Guided Combinatorial Phototherapy. Nanomedicine : Nanotechnology, Biology, and Medicine. PMID 27884637 DOI: 10.1016/J.Nano.2016.11.005 |
0.337 |
|
| 2016 |
Goloviznina NA, Verghese SC, Yoon YM, Taratula O, Marks DL, Kurre P. Mesenchymal Stromal Cell Derived Extracellular Vesicles Promote Myeloid Biased Multipotent Hematopoietic Progenitor Expansion via Toll-Like Receptor Engagement. The Journal of Biological Chemistry. PMID 27758863 DOI: 10.1074/Jbc.M116.745653 |
0.416 |
|
| 2016 |
Sapiezynski J, Taratula O, Rodriguez-Rodriguez L, Minko T. Precision targeted therapy of ovarian cancer. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 27746277 DOI: 10.1016/J.Jconrel.2016.10.014 |
0.584 |
|
| 2016 |
Li X, Taratula O, Taratula O, Schumann C, Minko T. LHRH-Targeted Drug Delivery Systems for Cancer Therapy. Mini Reviews in Medicinal Chemistry. PMID 27739358 DOI: 10.2174/1389557516666161013111155 |
0.636 |
|
| 2016 |
Schumann C, Chan SK, Khalimonchuk O, Khal S, Moskal V, Shah V, Alani AW, Taratula O, Taratula O. Mechanistic Nanotherapeutic Approach Based on siRNA-Mediated DJ-1 Protein Suppression for Platinum-Resistant Ovarian Cancer. Molecular Pharmaceutics. PMID 27170529 DOI: 10.1021/Acs.Molpharmaceut.6B00205 |
0.314 |
|
| 2015 |
Schumann C, Taratula O, Khalimonchuk O, Palmer AL, Cronk LM, Jones CV, Escalante CA, Taratula O. ROS-Induced Nanotherapeutic Approach for Ovarian Cancer Treatment Based on the Combinatorial Effect of Photodynamic Therapy and DJ-1 Gene Suppression. Nanomedicine : Nanotechnology, Biology, and Medicine. PMID 26238076 DOI: 10.1016/J.Nano.2015.07.005 |
0.351 |
|
| 2015 |
Taratula O, Patel M, Schumann C, Naleway MA, Pang AJ, He H, Taratula O. Phthalocyanine-loaded graphene nanoplatform for imaging-guided combinatorial phototherapy. International Journal of Nanomedicine. 10: 2347-62. PMID 25848255 DOI: 10.2147/Ijn.S81097 |
0.512 |
|
| 2015 |
Garbuzenko OB, Kuzmov A, Sapiezynski JE, Taratula O, Shah V, Zhang M, Savla R, John S, Rodriguez-Rodriguez L, Minko T. Abstract 4405: Tumor-targeted nanotherapeutics Cancer Research. 75: 4405-4405. DOI: 10.1158/1538-7445.Am2015-4405 |
0.564 |
|
| 2015 |
Taratula O, Doddapaneni BS, Schumann C, Li X, Bracha S, Milovancev M, Alani AWG. Naphthalocyanine-Based Biodegradable Polymeric Nanoparticles for Image-Guided Combinatorial Phototherapy Chemistry of Materials. 27: 6155-6165. DOI: 10.1021/Acs.Chemmater.5B03128 |
0.439 |
|
| 2014 |
Garbuzenko OB, Mainelis G, Taratula O, Minko T. Inhalation treatment of lung cancer: the influence of composition, size and shape of nanocarriers on their lung accumulation and retention. Cancer Biology & Medicine. 11: 44-55. PMID 24738038 DOI: 10.7497/J.Issn.2095-3941.2014.01.004 |
0.607 |
|
| 2013 |
Taratula O, Dani RK, Schumann C, Xu H, Wang A, Song H, Dhagat P, Taratula O. Multifunctional nanomedicine platform for concurrent delivery of chemotherapeutic drugs and mild hyperthermia to ovarian cancer cells. International Journal of Pharmaceutics. 458: 169-80. PMID 24091153 DOI: 10.1016/J.Ijpharm.2013.09.032 |
0.416 |
|
| 2013 |
Shah V, Taratula O, Garbuzenko OB, Taratula OR, Rodriguez-Rodriguez L, Minko T. Targeted nanomedicine for suppression of CD44 and simultaneous cell death induction in ovarian cancer: an optimal delivery of siRNA and anticancer drug. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 6193-204. PMID 24036854 DOI: 10.1158/1078-0432.Ccr-13-1536 |
0.643 |
|
| 2013 |
Taratula O, Schumann C, Naleway MA, Pang AJ, Chon KJ, Taratula O. A multifunctional theranostic platform based on phthalocyanine-loaded dendrimer for image-guided drug delivery and photodynamic therapy. Molecular Pharmaceutics. 10: 3946-58. PMID 24020847 DOI: 10.1021/Mp400397T |
0.458 |
|
| 2013 |
Taratula O, Kuzmov A, Shah M, Garbuzenko OB, Minko T. Nanostructured lipid carriers as multifunctional nanomedicine platform for pulmonary co-delivery of anticancer drugs and siRNA. Journal of Controlled Release : Official Journal of the Controlled Release Society. 171: 349-57. PMID 23648833 DOI: 10.1016/J.Jconrel.2013.04.018 |
0.645 |
|
| 2013 |
Shah V, Taratula O, Garbuzenko OB, Patil ML, Savla R, Zhang M, Minko T. Genotoxicity of different nanocarriers: possible modifications for the delivery of nucleic acids. Current Drug Discovery Technologies. 10: 8-15. PMID 22564170 DOI: 10.2174/1570163811310010003 |
0.629 |
|
| 2011 |
Taratula O, Garbuzenko OB, Chen AM, Minko T. Innovative strategy for treatment of lung cancer: targeted nanotechnology-based inhalation co-delivery of anticancer drugs and siRNA. Journal of Drug Targeting. 19: 900-14. PMID 21981718 DOI: 10.3109/1061186X.2011.622404 |
0.682 |
|
| 2011 |
Savla R, Taratula O, Garbuzenko O, Minko T. Tumor targeted quantum dot-mucin 1 aptamer-doxorubicin conjugate for imaging and treatment of cancer. Journal of Controlled Release : Official Journal of the Controlled Release Society. 153: 16-22. PMID 21342659 DOI: 10.1016/J.Jconrel.2011.02.015 |
0.641 |
|
| 2011 |
Taratula O, Garbuzenko O, Savla R, Wang YA, He H, Minko T. Multifunctional nanomedicine platform for cancer specific delivery of siRNA by superparamagnetic iron oxide nanoparticles-dendrimer complexes. Current Drug Delivery. 8: 59-69. PMID 21034421 DOI: 10.2174/156720111793663642 |
0.765 |
|
| 2011 |
Taratula O, Savla R, He H, Minko T. Poly(propyleneimine) dendrimers as potential siRNA delivery nanocarrier: From structure to function International Journal of Nanotechnology. 8: 36-52. DOI: 10.1504/Ijnt.2011.037169 |
0.707 |
|
| 2010 |
Chen AM, Taratula O, Wei D, Yen HI, Thomas T, Thomas TJ, Minko T, He H. Labile catalytic packaging of DNA/siRNA: control of gold nanoparticles "out" of DNA/siRNA complexes. Acs Nano. 4: 3679-88. PMID 20521827 DOI: 10.1021/Nn901796N |
0.726 |
|
| 2010 |
Cheung W, Pontoriero F, Taratula O, Chen AM, He H. DNA and carbon nanotubes as medicine. Advanced Drug Delivery Reviews. 62: 633-49. PMID 20338203 DOI: 10.1016/J.Addr.2010.03.007 |
0.53 |
|
| 2010 |
Minko T, Patil ML, Zhang M, Khandare JJ, Saad M, Chandna P, Taratula O. LHRH-targeted nanoparticles for cancer therapeutics. Methods in Molecular Biology (Clifton, N.J.). 624: 281-94. PMID 20217603 DOI: 10.1007/978-1-60761-609-2_19 |
0.687 |
|
| 2010 |
Xiao Y, Gao X, Cheung W, Urbas A, Taratula O, Holbrook D, Cavicchi RE, Souchek JJ, Wagner PD, Srivastava S, Avedisian T, He H, Batra S. Abstract 3686: Antibody-functionalized single-walled carbon nanotubes for detection and selective destruction of breast and pancreas cancer cells Cancer Research. 70: 3686-3686. DOI: 10.1158/1538-7445.Am10-3686 |
0.571 |
|
| 2009 |
Xiao Y, Gao X, Taratula O, Treado S, Urbas A, Holbrook RD, Cavicchi RE, Avedisian CT, Mitra S, Savla R, Wagner PD, Srivastava S, He H. Anti-HER2 IgY antibody-functionalized single-walled carbon nanotubes for detection and selective destruction of breast cancer cells. Bmc Cancer. 9: 351. PMID 19799784 DOI: 10.1186/1471-2407-9-351 |
0.555 |
|
| 2009 |
Chen AM, Zhang M, Wei D, Stueber D, Taratula O, Minko T, He H. Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells. Small (Weinheim An Der Bergstrasse, Germany). 5: 2673-7. PMID 19780069 DOI: 10.1002/Smll.200900621 |
0.677 |
|
| 2009 |
Taratula O, Garbuzenko OB, Kirkpatrick P, Pandya I, Savla R, Pozharov VP, He H, Minko T. Surface-engineered targeted PPI dendrimer for efficient intracellular and intratumoral siRNA delivery. Journal of Controlled Release : Official Journal of the Controlled Release Society. 140: 284-93. PMID 19567257 DOI: 10.1016/J.Jconrel.2009.06.019 |
0.749 |
|
| 2009 |
Patil ML, Zhang M, Taratula O, Garbuzenko OB, He H, Minko T. Internally cationic polyamidoamine PAMAM-OH dendrimers for siRNA delivery: effect of the degree of quaternization and cancer targeting. Biomacromolecules. 10: 258-66. PMID 19159248 DOI: 10.1021/Bm8009973 |
0.725 |
|
| 2009 |
Taratula O, Savla R, Pandya I, Wang A, Minko T, He H. Novel superparamagnetic iron oxide nanoparticles for a multifunctional nanomedicine platform Materials Research Society Symposium Proceedings. 1140: 93-98. |
0.663 |
|
| 2009 |
Taratula O, Kirkpatrick P, Savla R, Pandya I, Minko T, He H. Surface engineering for in vivo targeting delivery of siRNA for efficient cancer therapy Materials Research Society Symposium Proceedings. 1140: 65-71. |
0.669 |
|
| 2008 |
Patil ML, Zhang M, Betigeri S, Taratula O, He H, Minko T. Surface-modified and internally cationic polyamidoamine dendrimers for efficient siRNA delivery. Bioconjugate Chemistry. 19: 1396-403. PMID 18576676 DOI: 10.1021/Bc8000722 |
0.679 |
|
| 2008 |
Chen AM, Taratula O, Wei D, Minko T, He H. Labile catalytic packaging and delivering of short interference RNA to cancer cells: Control of gold nanoparticles "out" of siRNA complexes Technical Proceedings of the 2008 Nsti Nanotechnology Conference and Trade Show, Nsti-Nanotech, Nanotechnology 2008. 2: 342-345. |
0.612 |
|
| 2008 |
Taratula O, Kirkpatrick P, Savla R, Pandya I, Minko T, He H. Toward in vivo targeting delivery of siRNA for efficient cancer therapy Technical Proceedings of the 2008 Nsti Nanotechnology Conference and Trade Show, Nsti-Nanotech, Nanotechnology 2008. 2: 346-349. |
0.618 |
|
| 2008 |
Taratula O, Savia R, Pandya I, Geng H, Wang A, Minko T, He H. Multifunctional siRNA delivery system for cancer therapy Technical Proceedings of the 2008 Nsti Nanotechnology Conference and Trade Show, Nsti-Nanotech, Nanotechnology 2008. 2: 49-52. |
0.66 |
|
| 2007 |
Taratula O, Chen AM, Zhang J, Chaudry J, Nagahara L, Banerjee I, He H. Highly aligned ribbon-shaped Pd nanoparticle assemblies by spontaneous organization Journal of Physical Chemistry C. 111: 7666-7670. DOI: 10.1021/Jp0706937 |
0.499 |
|
| Show low-probability matches. |